CNL and NNL’s action plan, announced on 4 March, includes exploring joint research projects and studies, information exchange workshops and other resource and knowledge-sharing opportunities. They have identified research related to advanced nuclear reactor fuel, targeted alpha therapy and medical isotope production and environmental remediation practices and technologies as key areas they intend to pursue in partnership.
This follows an MoU they signed in 2016 to collaborate on a variety of projects in reactor metallurgy, fuel development, waste management and medical radioisotopes.
